| Betterchem |

|
|
|
| FDA approval activities
for this prescription drug:
Banan (cefpodoxime proxetil) Tablets and Suspension Sankyo Pharma NDA: 50-687/SE8-004, SE1-007, SE2-010, SE2-011 NDA: 50-688/SE8-006, SE1-008, SE2-011, SE2-012 Cefpodoxime Proxetil Tablets, Ranbaxy Limited ANDA 65-083 8/20/03 Cefpodoxime Proxetil Powder Suspension, Ranbaxy Limited ANDA 65-082 Vantin (cefpodoxime proxetil) Suspension, 5 mg/kg Pharmacia & Upjohn NDA 50-675/S-014 11/20/98 11/20/98 8/1/01 Vantin (cefpodoxime proxetil) Tablets and Vantin® (cefpodoxime proxetil) Suspension. Pharmacia & Upjohn NDA 50-674/S-012 50-675/S-015 CEFPODOXIME PROXETIL For Suspension; 100MG BASE/5ML VANTIN PHARMACIA AND UPJOHN 050675 CEFPODOXIME PROXETIL For Suspension; 50MG BASE/5ML VANTIN PHARMACIA AND UPJOHN 065082 CEFPODOXIME PROXETIL For Suspension; 100MG BASE/5ML CEFPODOXIME PROXETIL RANBAXY 065082 CEFPODOXIME PROXETIL For Suspension; 50MG BASE/5ML CEFPODOXIME PROXETIL RANBAXY 050674 CEFPODOXIME PROXETIL Tablet; 100MG BASE VANTIN PHARMACIA AND UPJOHN 050674 CEFPODOXIME PROXETIL Tablet; 200MG BASE VANTIN PHARMACIA AND UPJOHN 065083 CEFPODOXIME PROXETIL Tablet; 100MG BASE CEFPODOXIME PROXETIL RANBAXY 065083 CEFPODOXIME PROXETIL Tablet; 200MG BASE CEFPODOXIME PROXETIL RANBAXY |
© 2009 Betterchem.com
|